Stay updated on Avelumab first-line maintenance in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Avelumab first-line maintenance in Gastric Cancer Clinical Trial page.

Latest updates to the Avelumab first-line maintenance in Gastric Cancer Clinical Trial page
- Check4 days agoChange DetectedThe study record now displays details for the completed JAVELIN Gastric 100 trial, including its design, treatments, eligibility criteria, locations, and outcome measures, along with study documents and links.SummaryDifference100%

- Check11 days agoChange DetectedThe site footer revision changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedA site-wide notice about NIH terminology changes appears above the 403 error page, and the site revision label is updated from v3.7.1 to v3.7.2.SummaryDifference1%

- Check39 days agoChange DetectedThe site footer revision number changes from v3.7.0 to v3.7.1 on the 403 Forbidden page.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page now shows a 403 Forbidden error with a Home button, replacing the previous study record content.SummaryDifference19%

- Check60 days agoChange DetectedThe page now displays Revision: v3.7.0, replacing the previous v3.6.6. This indicates a software deployment or update to the page’s UI/back-end, without altering the study data.SummaryDifference0.0%

Stay in the know with updates to Avelumab first-line maintenance in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab first-line maintenance in Gastric Cancer Clinical Trial page.